Zacks Small-Cap Research Initiates Coverage on NewGen
Rhea-AI Summary
NewGen (NASDAQ:NIVF) announced that Zacks Small-Cap Research initiated equity research coverage on October 10, 2025. The announcement notes NewGen is a tech-forward, multi-jurisdictional growth company operating in real estate development, digital asset management and reproductive health solutions. The full Zacks equity research report is available on the Zacks website.
Positive
- None.
Negative
- None.
News Market Reaction – NIVF
On the day this news was published, NIVF declined 5.24%, reflecting a notable negative market reaction. This price movement removed approximately $227K from the company's valuation, bringing the market cap to $4.11M at that time.
Data tracked by StockTitan Argus on the day of publication.
BANGKOK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that Zacks Small-Cap Research ("Zacks") has initiated equity research coverage on the Company. The full equity research report is available on the Zacks website here.
About NewGen
NewGenIVF Group is a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through three strategic business divisions that leverage cutting-edge technology and innovative solutions to drive sustainable growth and high ROI for shareholders across multiple global markets. These include “NewGenProperty”, which operates lucrative real estate development projects in the UAE's Ras Al Khaimah Emirate; “NewGenDigital”, which serves as the Company's digital asset and DeFi solutions arm; and "NewGenSup”, which focuses on health and longevity products and solutions. NewGen’s legacy business involves providing industry-leading IVF and assisted reproductive treatment services across Asia. With operations spanning multiple jurisdictions and a commitment to innovative, technology-enabled solutions, NewGenIVF Group is uniquely positioned to capitalize on the convergence of real estate, healthcare and digital asset opportunities in the evolving global economy.
To learn more, visit www.newgenivf.com. The information contained on, or accessible through, NewGen’s website is not incorporated by reference into this press release, and you should not consider it a part of this press release.
Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: Newgenivf.IR@icrinc.com
